ArticleBritish journal of cancer2023

Genome-wide CRISPR screening reveals ADCK3 as a key regulator in sensitizing endometrial carcinoma cells to MPA therapy.

Zijing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.